Journal
HEART
Volume 99, Issue 12, Pages 866-872Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/heartjnl-2013-303640
Keywords
-
Categories
Funding
- University Medical Centre Utrecht
- Merck
- Netherlands Organisation for Health Research and Development
- Catharijne foundation Utrecht
- AstraZeneca
- Novartis
- Amgen
Ask authors/readers for more resources
Objectives To enable risk stratification of patients with various types of arterial disease by the development and validation of models for prediction of recurrent vascular event risk based on vascular risk factors, imaging or both. Design Prospective cohort study. Setting University Medical Centre. Patients 5788 patients referred with various clinical manifestations of arterial disease between January 1996 and February 2010. Main outcome measures 788 recurrent vascular events (ie, myocardial infarction, stroke or vascular death) that were observed during 4.7 (IQR 2.3 to 7.7) years' follow-up. Results Three Cox proportional hazards models for prediction of 10-year recurrent vascular event risk were developed based on age and sex in addition to clinical parameters (model A), carotid ultrasound findings (model B) or both (model C). Clinical parameters were medical history, current smoking, systolic blood pressure and laboratory biomarkers. In a separate part of the dataset, the concordance statistic of model A was 0.68 (95% CI 0.64 to 0.71), compared to 0.64 (0.61 to 0.68) for model B and 0.68 (0.65 to 0.72) for model C. Goodness-of-fit and calibration of model A were adequate, also in separate subgroups of patients having coronary, cerebrovascular, peripheral artery or aneurysmal disease. Model A predicted <20% risk in 59% of patients, 20-30% risk in 19% and >30% risk in 23%. Conclusions Patients at high risk for recurrent vascular events can be identified based on readily available clinical characteristics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available